Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782308 · ClinicalTrials.gov registry record
Tinnitus Patient Preferences Survey
A clinical trial of Tinnitus, Subjective and Tinnitus, Noise Induced, sponsored by Nicolas Gninenko.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06782308: Recruiting study of Tinnitus, Subjective and Tinnitus, Noise Induced, sponsored by Nicolas Gninenko.
NCT06782308 is a study of Tinnitus, Subjective and Tinnitus, Noise Induced that is actively recruiting participants, run by Nicolas Gninenko. The registered enrollment target is 500 participants, above the 73-participant average among 4 other Tinnitus, Subjective trials with a reported enrollment target (585% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06782308, a study of Tinnitus, Subjective and Tinnitus, Noise Induced, is actively recruiting participants, sponsored by Nicolas Gninenko.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.
Primary Outcome
Risks acceptance and user preferences will be assessed through responses to the survey. The outcome will be summarized in the form of a percentage or similar statistics on acceptances rates for surgical interventions in patients with chronic tinnitus. Acceptance rates will also be evaluated in accordance to several clinical characteristics of tinnitus, such as its perceived annoyance or loudness.
Conditions Studied
Interventions
- OTHER Survey using a questionnaire.
Study Locations (1)
New York
- Neurosoft Bielectronics US Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2025-12-30 |
What NCT06782308 shows while recruiting
NCT06782308 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 73-participant average among 4 other Tinnitus, Subjective trials with a reported enrollment target (585% higher).
The record links to 4 conditions, with Tinnitus, Subjective appearing as the primary indexed condition, and to 1 intervention - of which Survey using a questionnaire. is the first listed.
NCT06782308 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06782308 about?
NCT06782308 is a clinical study titled "Tinnitus Patient Preferences Survey". The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks relate...
What is the current status of trial NCT06782308?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-01-13. Estimated completion is 2025-12-30.
What conditions does trial NCT06782308 study?
This clinical trial studies the following conditions: Tinnitus, Subjective, Tinnitus, Noise Induced, Tinnitus, Bilateral, Tinnitus, Hearing Loss, Cochlear Implant Users.
What interventions are being tested in trial NCT06782308?
The interventions under investigation include: Survey using a questionnaire. (OTHER).
Who is sponsoring clinical trial NCT06782308?
This trial is sponsored by Nicolas Gninenko, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782308 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus, Subjective
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI